Darwin AG (XTER:7V0) Gross-Profit-to-Asset % : 3.00% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Darwin AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Darwin AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was €6.03 Mil. Darwin AG's average Total Assets over the quarter that ended in Dec. 2023 was €201.36 Mil. Therefore, Darwin AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 3.00%.

Darwin AG Gross-Profit-to-Asset % Historical Data

The historical data trend for Darwin AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Darwin AG Gross-Profit-to-Asset % Chart

Darwin AG Annual Data

Trend

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

34.36

62.16

3.00

Darwin AG Semi-Annual Data
	Dec21	Dec22	Dec23
Gross-Profit-to-Asset %	34.36	62.16	3.00

Competitive Comparison of Darwin AG's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Darwin AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Darwin AG's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Darwin AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Darwin AG's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Darwin AG Gross-Profit-to-Asset % Calculation

Darwin AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	6.034	/	( (223.812	+	178.898)	/ 2 )
	=	6.034	/	201.355
	=	3.00 %

Darwin AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	6.034	/	( (223.812	+	178.898)	/ 2 )
	=	6.034	/	201.355
	=	3.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Darwin AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Darwin AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Darwin AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Darwin AG (XTER:7V0) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Brienner Strasse 7, Munich, BY, DEU, D-80333

Website

https://darwin-biotech.com

Darwin AG is a biotechnology company. It is engaged in the field of human genetics. The group also develops and sells personalized dietary supplements and cosmetics. Its brand includes Novodaily; Rootine and Genopedia.

Darwin AG Headlines

No Headlines